002821 凯莱英
交易中 03-27 09:32:00
资讯
新帖
简况
凯莱英（002821）披露召开2026年第一次临时股东会等三会通知，3月25日股价上涨0.95%
证券之星 · 03-25 22:10
凯莱英（002821）披露召开2026年第一次临时股东会等三会通知，3月25日股价上涨0.95%
凯莱英（002821）披露董事会会议日期公告，3月16日股价下跌0.23%
证券之星 · 03-16
凯莱英（002821）披露董事会会议日期公告，3月16日股价下跌0.23%
凯莱英(06821)购回及注销部分根据2025年A股计划授予的限制性A股股份
智通财经 · 03-13
凯莱英(06821)购回及注销部分根据2025年A股计划授予的限制性A股股份
凯莱英：拟使用45.00亿闲置自有资金购买理财产品
南方财经网 · 03-13
凯莱英：拟使用45.00亿闲置自有资金购买理财产品
凯莱英（002821）披露证券变动月报表，3月3日股价下跌2.05%
证券之星 · 03-03
凯莱英（002821）披露证券变动月报表，3月3日股价下跌2.05%
花旗集团增持凯莱英H股，持股比例从9.34%升至11.67%
美股速递 · 02-25
花旗集团增持凯莱英H股，持股比例从9.34%升至11.67%
小摩增持凯莱英(06821)9400股 每股作价约87.56港元
智通财经 · 02-13
小摩增持凯莱英(06821)9400股 每股作价约87.56港元
小摩增持凯莱英(06821)4700股 每股作价80.6776港元
智通财经网 · 02-09
小摩增持凯莱英(06821)4700股 每股作价80.6776港元
Norges Bank增持凯莱英(06821)5.35万股 每股作价约79.01港元
智通财经 · 02-06
Norges Bank增持凯莱英(06821)5.35万股 每股作价约79.01港元
摩根大通减持凯莱英(06821)1.98万股 每股作价约78.64港元
智通财经 · 02-06
摩根大通减持凯莱英(06821)1.98万股 每股作价约78.64港元
摩根大通减持凯莱英(06821)0.78万股 每股作价约80.84港元
智通财经 · 02-03
摩根大通减持凯莱英(06821)0.78万股 每股作价约80.84港元
Norges Bank增持凯莱英(06821)9.97万股 每股作价约80.67港元
智通财经 · 01-29
Norges Bank增持凯莱英(06821)9.97万股 每股作价约80.67港元
凯莱英(06821)根据H股限制性股票计划发行28.13万股
智通财经 · 01-26
凯莱英(06821)根据H股限制性股票计划发行28.13万股
凯莱英公布国际专利申请：“一种Patisiran的制备方法”
证券之星 · 01-24
凯莱英公布国际专利申请：“一种Patisiran的制备方法”
凯莱英公布国际专利申请：“治疗α1-抗胰蛋白酶缺乏症的siRNA的制备方法”
证券之星 · 01-24
凯莱英公布国际专利申请：“治疗α1-抗胰蛋白酶缺乏症的siRNA的制备方法”
凯莱英公布国际专利申请：“可溶性表达质粒突变体库的构建方法及其应用”
证券之星 · 01-24
凯莱英公布国际专利申请：“可溶性表达质粒突变体库的构建方法及其应用”
申庆2025年四季度表现，兴全沪深300指数增强(LOF)Y基金季度涨幅2.69%
证券之星 · 01-22
申庆2025年四季度表现，兴全沪深300指数增强(LOF)Y基金季度涨幅2.69%
股市必读：凯莱英（002821）1月21日董秘有最新回复
证券之星 · 01-22
股市必读：凯莱英（002821）1月21日董秘有最新回复
Norges Bank减持凯莱英(06821)11万股 每股作价约88.2港元
智通财经网 · 01-19
Norges Bank减持凯莱英(06821)11万股 每股作价约88.2港元
股市必读：凯莱英（002821）1月16日董秘有最新回复
证券之星 · 01-19
股市必读：凯莱英（002821）1月16日董秘有最新回复
加载更多
公司概况
公司名称：
凯莱英医药集团(天津)股份有限公司
所属行业：
医药制造业
上市日期：
2016-11-18
主营业务：
凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是临床阶段CDMO解决方案、商业化阶段CDMO解决方案、新兴服务。截至报告期末公司共有国内外已授权专利538项，其中国内专利423项，国外专利115项，其中183项在合成生物领域，204项在连续反应技术领域。
发行价格：
30.53
{"stockData":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":96.83,"timestamp":1774575120000,"preClose":96.8,"halted":0,"volume":102604,"delay":0,"changeRate":0.0003,"floatShares":317000000,"shares":361000000,"eps":2.8788,"marketStatus":"交易中","change":0.03,"latestTime":"03-27 09:32:00","open":96.18,"high":97.37,"low":96.01,"amount":9911500,"amplitude":0.014,"askPrice":96.83,"askSize":16,"bidPrice":96.8,"bidSize":1,"shortable":0,"etf":0,"ttmEps":2.8788,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1774582200000},"marketStatusCode":2,"adr":0,"adjPreClose":96.8,"symbolType":"stock","openAndCloseTimeList":[[1774575000000,1774582200000],[1774587600000,1774594800000]],"highLimit":106.48,"lowLimit":87.12,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":360874970,"isCdr":false,"pbRate":2.01,"roa":"--","peRate":33.635543,"roe":"4.63%","epsLYR":2.69,"committee":-0.230769,"marketValue":34944000000,"turnoverRate":0.0003,"status":0,"hkstockBrief":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":76.2,"timestamp":1774575083891,"preClose":75.75,"halted":0,"volume":2300,"delay":0,"premium":"-30.43"},"floatMarketCap":30699000000},"requestUrl":"/m/hq/s/002821","defaultTab":"news","newsList":[{"id":"2622074424","title":"凯莱英（002821）披露召开2026年第一次临时股东会等三会通知，3月25日股价上涨0.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622074424","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622074424?lang=zh_cn&edition=full","pubTime":"2026-03-25 22:10","pubTimestamp":1774447827,"startTime":"0","endTime":"0","summary":"截至2026年3月25日收盘，凯莱英报收于96.5元，较前一交易日上涨0.95%，最新总市值为348.24亿元。近日，凯莱英医药集团（天津）股份有限公司发布《关于召开2026年第一次临时股东会、2026年第一次A股类别股东会及2026年第一次H股类别股东会的通知》。会议将审议修订董事及高级管理人员薪酬管理制度、回购注销2025年A股限制性股票激励计划部分限制性股票、修订公司章程等议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500043643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1328615791.USD","06821","BK0132","BK0239","002821","BK1191"],"gpt_icon":0},{"id":"2619461785","title":"凯莱英（002821）披露董事会会议日期公告，3月16日股价下跌0.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619461785","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619461785?lang=zh_cn&edition=full","pubTime":"2026-03-16 22:29","pubTimestamp":1773671358,"startTime":"0","endTime":"0","summary":"截至2026年3月16日收盘，凯莱英报收于99.08元，较前一交易日下跌0.23%，最新总市值为357.55亿元。该股当日开盘98.94元，最高100.74元，最低97.08元，成交额达2.66亿元，换手率为0.85%。近日，凯莱英医药集团（天津）股份有限公司发布H股公告，宣布将于2026年3月30日举行董事会会议，考虑及批准公司及其附属公司截至2025年12月31日止年度业绩的发布，并考虑建议派发末期股息（如有）。公告同时列出了董事会成员名单。本公告由董事长Hao Hong博士代表董事会签署。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600036892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","LU1328615791.USD","BK0239","BK0132","BK1191","002821"],"gpt_icon":0},{"id":"2619719796","title":"凯莱英(06821)购回及注销部分根据2025年A股计划授予的限制性A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2619719796","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619719796?lang=zh_cn&edition=full","pubTime":"2026-03-13 20:57","pubTimestamp":1773406667,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，于2026年3月13日，本公司董事会审议并通过了“关于购回及注销 2025年A股计划项下部分限制性股份的议案”，据此将购回及注销共计6.1万股由 (i)四名已辞职激励对象根据2025年A股计划首次授予，及(ii)一名已辞职激励对象根据2025年A股计划预留授予项下所持有的已授出但尚未解禁的限制性A股股份(购回及注销事项)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1191","06821","159982","LU1328615791.USD","BK0132","002821","399300"],"gpt_icon":0},{"id":"2619219669","title":"凯莱英：拟使用45.00亿闲置自有资金购买理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2619219669","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619219669?lang=zh_cn&edition=full","pubTime":"2026-03-13 18:40","pubTimestamp":1773398408,"startTime":"0","endTime":"0","summary":"南财智讯3月13日电，凯莱英公告，公司及合并报表范围内子公司拟使用额度不超过45.00亿元人民币（或等额外币，含本数）的闲置自有资金购买安全性高、流动性好的短期金融机构理财产品，使用期限自2026年3月13日第五届董事会第七次会议审议通过之日起不超过12个月，在上述额度和期限内，资金可循环使用。该事项已经公司董事会审议通过，无需提交股东大会审议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603133671676352.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0132","BK1191","06821","002821","BK0239","LU1328615791.USD"],"gpt_icon":0},{"id":"2616641326","title":"凯莱英（002821）披露证券变动月报表，3月3日股价下跌2.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616641326","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616641326?lang=zh_cn&edition=full","pubTime":"2026-03-03 22:18","pubTimestamp":1772547505,"startTime":"0","endTime":"0","summary":"截至2026年3月3日收盘，凯莱英报收于92.5元，较前一交易日下跌2.05%，最新总市值为333.81亿元。近日，凯莱英医药集团（天津）股份有限公司提交截至2026年2月28日的证券变动月报表。公司H股和A股的法定/注册股本均无变动，H股总数为27,834,510股，A股总数为333,040,460股，其中A股包含1,151,300股库存股。已发行股份总数保持不变，H股无库存股。公司确认H股公众持股量符合联交所规定的5%最低门槛。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300044360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","BK0239","BK1191","06821","LU1328615791.USD","BK0132","002821"],"gpt_icon":0},{"id":"1131840699","title":"花旗集团增持凯莱英H股，持股比例从9.34%升至11.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131840699","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131840699?lang=zh_cn&edition=full","pubTime":"2026-02-25 19:32","pubTimestamp":1772019171,"startTime":"0","endTime":"0","summary":"根据香港交易所披露的最新权益资料，花旗集团于2月19日增持了凯莱英的H股股份，其持有的好仓权益比例由9.34%增加至11.67%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821","BK0132","BK0239","BK1191","LU1328615791.USD","002821"],"gpt_icon":0},{"id":"2611715405","title":"小摩增持凯莱英(06821)9400股 每股作价约87.56港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611715405","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611715405?lang=zh_cn&edition=full","pubTime":"2026-02-13 20:43","pubTimestamp":1770986605,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，2月10日，小摩增持凯莱英(06821)9400股，每股作价87.5591港元，总金额约为82.31万港元。增持后最新持股数目约为167.41万股，最新持股比例为6.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405425.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1551013425.SGD","LU2237443465.HKD","LU0251132253.USD","LU1670627923.USD","BK0132","IE00BLSP4239.USD","06821","LU0820561909.HKD","LU2417539215.USD","LU1720051017.SGD","LU0211327993.USD","LU0203347892.USD","LU0323591593.USD","IE00BJTD4V19.USD","LU0170899867.USD","LU0976567544.SGD","BK4533","IE00BYXW3230.USD","LU2430703095.HKD","LU1548497426.USD","LU0211331839.USD","LU0267386448.USD","LU2746668461.USD","LU0943347566.SGD","IE00BJLML261.HKD","LU0211326839.USD","LU0256863811.USD","LU2552382132.HKD","LU2430703251.USD","BK4566","LU1974910355.USD","LU0971096721.USD","LU0203345920.USD","IE00B3S45H60.SGD","LU1280957306.USD","LU1328615791.USD","LU2242649171.HKD","002821","LU0215105999.USD","LU1629891620.HKD","LU2054465674.USD","LU0238689110.USD","LU0208291251.USD","LU0211326755.USD","LU1244550577.SGD","LU1894683264.USD","LU0149725797.USD","LU2381873111.SGD","IE00BBT3K403.USD","LU0882574139.USD"],"gpt_icon":0},{"id":"2610634376","title":"小摩增持凯莱英(06821)4700股 每股作价80.6776港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610634376","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610634376?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:04","pubTimestamp":1770635051,"startTime":"0","endTime":"0","summary":"增持后最新持股数目约为167.27万股，最新持股比例为6%。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260209/20260209190438_74749.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260209/20260209190438_74749.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403274.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IE00BLSP4239.USD","LU2756315664.SGD","LU1244550577.SGD","LU0211327993.USD","LU0882574139.USD","IE00BDCRKT87.USD","LU0496365809.HKD","LU1551013425.SGD","LU0265550359.USD","LU1328615791.USD","BK4585","LU2756315318.SGD","BK4504","IE00B1BXHZ80.USD","LU1894683264.USD","06821","LU2237443622.USD","BK4534","LU2023250330.USD","LU0149725797.USD","LU2264538146.SGD","LU2746668974.SGD","LU0234572021.USD","BK0132","LU1670627923.USD","LU1917777945.USD","LU1032466523.USD","BK4207","IE00B1XK9C88.USD","LU0820561909.HKD","LU2505996681.GBP","LU1894683348.USD","LU0787776722.HKD","002821","IE0034235188.USD","SG9999002232.USD","LU0345770993.USD","LU1914381329.SGD","BK0239","BK4581","LU0964807845.USD","LU2237443382.USD","LU2462157665.USD","LU0208291251.USD","IE00BJTD4V19.USD","LU1145028129.USD","LU2456880835.USD","IE00BLSP4452.SGD","LU0323591593.USD","IE00B775SV38.USD"],"gpt_icon":0},{"id":"2609967665","title":"Norges Bank增持凯莱英(06821)5.35万股 每股作价约79.01港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609967665","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609967665?lang=zh_cn&edition=full","pubTime":"2026-02-06 21:11","pubTimestamp":1770383491,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，2月3日，Norges Bank增持凯莱英(06821)5.35万股，每股作价79.0068港元，总金额约为422.69万港元。增持后最新持股数目为450.65万股，最新持股比例为16.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402777.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1328615791.USD","06821","BK0239","BK1191","BK0132","002821"],"gpt_icon":0},{"id":"2609967595","title":"摩根大通减持凯莱英(06821)1.98万股 每股作价约78.64港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609967595","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609967595?lang=zh_cn&edition=full","pubTime":"2026-02-06 21:10","pubTimestamp":1770383420,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，2月3日，摩根大通减持凯莱英(06821)1.98万股，每股作价78.6378港元，总金额约为155.7万港元。减持后最新持股数目约为166.8万股，持股比例为5.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402775.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0868494617.USD","IE00BYXW3230.USD","LU2023250504.SGD","LU2381873111.SGD","IE0034235295.USD","IE00BWXC8680.SGD","LU0976567544.SGD","LU0683600562.USD","LU1988902786.USD","BK4581","LU0496365809.HKD","LU2054465674.USD","LU0942090050.USD","IE00BZ1G4Q59.USD","LU1162221912.USD","SG9999002232.USD","BK4585","06821","LU0265550359.USD","LU0048584097.USD","LU1894683348.USD","LU0203345920.USD","LU2237443549.SGD","LU2417539215.USD","LU2242649171.HKD","LU2430703095.HKD","LU0265550946.USD","LU2552382058.USD","LU2430703178.SGD","LU0971096721.USD","LU1267930490.SGD","BK4516","LU0320765646.SGD","LU0787776722.HKD","IE000M9KFDE8.USD","IE00B3S45H60.SGD","LU2106854487.HKD","LU2456880835.USD","IE00B1XK9C88.USD","LU0267386448.USD","LU0345770993.USD","LU0149725797.USD","IE00BJTD4N35.SGD","LU1720051017.SGD","LU0417517546.SGD","LU1548497426.USD","002821","LU1551013342.USD","LU0211328371.USD","LU0345770308.USD"],"gpt_icon":0},{"id":"2608827060","title":"摩根大通减持凯莱英(06821)0.78万股 每股作价约80.84港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608827060","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608827060?lang=zh_cn&edition=full","pubTime":"2026-02-03 18:59","pubTimestamp":1770116376,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，1月28日，摩根大通减持凯莱英(06821)0.78万股，每股作价80.8366港元，总金额约为63.05万港元。减持后最新持股数目约为166.27万股，持股比例为5.97%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0265550359.USD","IE00BJTD4V19.USD","BK4588","LU2505996681.GBP","LU1363072403.SGD","LU2237443465.HKD","IE00BLSP4452.SGD","LU2417539215.USD","BK4550","LU0215105999.USD","BK0132","IE00BKVL7J92.USD","LU2211815571.USD","IE00B3S45H60.SGD","LU1894683348.USD","SG9999002232.USD","LU0323591593.USD","LU0964807845.USD","LU2505996509.AUD","LU0070302665.USD","LU0170899867.USD","BK4533","06821","LU1116320901.HKD","LU1974910355.USD","LU2213496289.HKD","IE00B1BXHZ80.USD","LU1119994496.HKD","LU0943347566.SGD","LU0310799852.SGD","IE00BKDWB100.SGD","LU0820561909.HKD","LU1548497426.USD","LU1328615791.USD","LU1064131342.USD","IE00BJTD4N35.SGD","LU0211326839.USD","BK0239","LU1917777945.USD","SG9999002224.SGD","LU1551013342.USD","LU1261432733.SGD","LU2236285917.USD","LU0238689110.USD","LU0820561818.USD","002821","LU1267930490.SGD","BK1191","LU2237443382.USD","LU0267386448.USD"],"gpt_icon":0},{"id":"2607085321","title":"Norges Bank增持凯莱英(06821)9.97万股 每股作价约80.67港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607085321","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607085321?lang=zh_cn&edition=full","pubTime":"2026-01-29 18:53","pubTimestamp":1769684007,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，1月28日，Norges Bank增持凯莱英(06821)9.97万股，每股作价80.6683港元，总金额约为804.26万港元。增持后最新持股数目为423.53万股，最新持股比例为15.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","LU1328615791.USD","002821","06821","BK0239","BK1191"],"gpt_icon":0},{"id":"2606436842","title":"凯莱英(06821)根据H股限制性股票计划发行28.13万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606436842","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606436842?lang=zh_cn&edition=full","pubTime":"2026-01-26 21:21","pubTimestamp":1769433672,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，该公司于2026年1月26日根据H股限制性股票计划向受托人发行并配发股份28.13万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397585.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002821","BK0132","BK0239","06821","BK1191","LU1328615791.USD"],"gpt_icon":0},{"id":"2605281276","title":"凯莱英公布国际专利申请：“一种Patisiran的制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2605281276","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605281276?lang=zh_cn&edition=full","pubTime":"2026-01-24 08:50","pubTimestamp":1769215845,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示凯莱英（002821）公布了一项国际专利申请，专利名为“一种Patisiran的制备方法”，专利申请号为PCT/CN2025/079387，国际公布日为2026年1月15日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来凯莱英已公布的国际专利申请12个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了2.86亿元，同比减13.06%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012400011772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK1191","002821","06821","LU1328615791.USD","BK0239"],"gpt_icon":0},{"id":"2605817532","title":"凯莱英公布国际专利申请：“治疗α1-抗胰蛋白酶缺乏症的siRNA的制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2605817532","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605817532?lang=zh_cn&edition=full","pubTime":"2026-01-24 08:50","pubTimestamp":1769215841,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示凯莱英（002821）公布了一项国际专利申请，专利名为“治疗α1-抗胰蛋白酶缺乏症的siRNA的制备方法”，专利申请号为PCT/CN2025/079380，国际公布日为2026年1月15日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来凯莱英已公布的国际专利申请12个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了2.86亿元，同比减13.06%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012400011740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","002821","BK1191","BK0132","LU1328615791.USD","BK0239"],"gpt_icon":0},{"id":"2605281743","title":"凯莱英公布国际专利申请：“可溶性表达质粒突变体库的构建方法及其应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2605281743","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605281743?lang=zh_cn&edition=full","pubTime":"2026-01-24 08:50","pubTimestamp":1769215839,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示凯莱英（002821）公布了一项国际专利申请，专利名为“可溶性表达质粒突变体库的构建方法及其应用”，专利申请号为PCT/CN2025/071619，国际公布日为2026年1月15日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来凯莱英已公布的国际专利申请12个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了2.86亿元，同比减13.06%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012400011726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","002821","BK0132","LU1328615791.USD","BK0239","06821"],"gpt_icon":0},{"id":"2605439034","title":"申庆2025年四季度表现，兴全沪深300指数增强(LOF)Y基金季度涨幅2.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605439034","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605439034?lang=zh_cn&edition=full","pubTime":"2026-01-22 07:10","pubTimestamp":1769037005,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2025年四季度末，基金经理申庆旗下共管理3只基金，本季度表现最佳的为兴全沪深300指数增强Y，季度净值涨2.69%。申庆在担任兴全沪深300指数A基金经理的任职期间累计任职回报180.51%，平均年化收益率为7.01%。持有期间的估算收益率为530.35%，持有期间凯莱英在2017年到2021年的年报营业总收入增幅达225.98%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200004315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002044","159967","512510","399006","510300","515890","06821","300353","000300.SH","000688.SH","512880","510880","002821","399001","000905.SH"],"gpt_icon":0},{"id":"2605849344","title":"股市必读：凯莱英（002821）1月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605849344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605849344?lang=zh_cn&edition=full","pubTime":"2026-01-22 01:29","pubTimestamp":1769016548,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘，凯莱英报收于103.8元，上涨0.58%，换手率1.23%，成交量3.91万手，成交额4.09亿元。董秘最新回复投资者： 贵司小分子PPQ项目的减少，是否意味着小分子商业化项目的减少？当日关注点来自交易信息汇总：1月21日主力资金净流入1747.64万元，呈现明显吸筹迹象。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200000610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1328615791.USD","002821","BK0132","06821","BK1191","BK0239"],"gpt_icon":0},{"id":"2604013818","title":"Norges Bank减持凯莱英(06821)11万股 每股作价约88.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604013818","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604013818?lang=zh_cn&edition=full","pubTime":"2026-01-19 19:08","pubTimestamp":1768820899,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，1月14日，Norges Bank减持凯莱英(06821)11万股，每股作价88.1971港元，总金额约为970.17万港元。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260119/20260119190838_98807.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260119/20260119190838_98807.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0132","002821","BK1191","LU1328615791.USD","06821","BK0239"],"gpt_icon":0},{"id":"2604597901","title":"股市必读：凯莱英（002821）1月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2604597901","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604597901?lang=zh_cn&edition=full","pubTime":"2026-01-19 01:28","pubTimestamp":1768757289,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，凯莱英报收于107.33元，上涨0.78%，换手率1.88%，成交量5.97万手，成交额6.39亿元。公司所服务的PPQ项目数量会随着公司所服务的项目进展，比如获批上市等情况动态变化。当日关注点来自交易信息汇总：1月16日主力资金净流出4067.55万元，游资资金净流入4069.08万元，呈现主力与游资反向操作态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900000525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1328615791.USD","BK1191","BK0132","002821","BK0239","06821"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774575122763,"stockEarnings":[{"period":"1week","weight":0.0077},{"period":"1month","weight":-0.0258},{"period":"3month","weight":0.0168},{"period":"6month","weight":-0.1017},{"period":"1year","weight":0.2645},{"period":"ytd","weight":0.0416}],"compareEarnings":[{"period":"1week","weight":-0.0293},{"period":"1month","weight":-0.0555},{"period":"3month","weight":-0.0188},{"period":"6month","weight":0.0159},{"period":"1year","weight":0.1545},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"凯莱英医药集团(天津)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2016-11-18","address":"天津市滨海新区经济技术开发区洞庭三街6号","registeredCapital":"36087万元","survey":" 凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是临床阶段CDMO解决方案、商业化阶段CDMO解决方案、新兴服务。截至报告期末公司共有国内外已授权专利538项，其中国内专利423项，国外专利115项，其中183项在合成生物领域，204项在连续反应技术领域。","listedPrice":30.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,002821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}